Startseite>>Signaling Pathways>> Immunology/Inflammation>> Adaptive Immunity>>Bisindolylmaleimide XI (hydrochloride)

Bisindolylmaleimide XI (hydrochloride) (Synonyms: BIM XI, Ro 310432)

Katalog-Nr.GC18716

Bisindolylmaleimid XI (Hydrochlorid) (Ro 32-0432) ist ein potenter, selektiver und oral aktiver PKC-Inhibitor mit IC50-Werten von 9 nM, 28 nM, 31 nM, 37 nM und 108 nM für PKCα, PKCβI, PKCβII, PKCγ und PKCε , beziehungsweise.

Products are for research use only. Not for human use. We do not sell to patients.

Bisindolylmaleimide XI (hydrochloride) Chemische Struktur

Cas No.: 145333-02-4

Größe Preis Lagerbestand Menge
1mg
121,00 $
Auf Lager
5mg
503,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products
Bisindolylmaleimide XI (BIM XI) is a selective, cell-permeable protein kinase C (PKC) inhibitor that displays 10-fold greater selectivity for PKCα (IC50 = 9 nM) and 4-fold greater selectivity for PKCβI (IC50 = 28 nM) over Ca2+-independent PKCε (IC50 = 108 nM). Inhibition of PKCα by BIM XI and other similar PKC inhibitors has been associated with enhanced cardiac contractility and protection from heart failure. BIM XI prevents T-cell activation and proliferation (with IC50s ranging from 30-150 nM) associated with chronic inflammatory responses in vivo.

Bewertungen

Review for Bisindolylmaleimide XI (hydrochloride)

Average Rating: 5 ★★★★★ (Based on Reviews and 31 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Bisindolylmaleimide XI (hydrochloride)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.